Skip to content
Bored Studies
RecruitingAccepts healthy volunteersEarly Phase 1

Role of ET-1, Physical Activity, and Sedentary Behavior in Microvascular Dysfunction Following GDM

Anna Stanhewicz, PhD · NCT06547619

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18–50 · Women only
Healthy volunteers
Accepted
Study type
Interventional · Early Phase 1
Target enrollment
40
US sites recruiting
1
Study start
October 1, 2024
Record last updated
July 29, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

Women with a history of gestational diabetes mellitus (GDM) are at a 2-fold greater risk for the development of overt cardiovascular disease (CVD) following the effected pregnancy. While subsequent development of type II diabetes elevates this risk, prior GDM is an independent risk factor for CVD morbidity, particularly, within the first decade postpartum. GDM is associated with impaired endothelial function during pregnancy and decrements in macro- and microvascular function persist postpartum, despite the remission of insulin resistance following delivery. Collectively, while the association between GDM and elevated lifetime CVD risk is clear, and available evidence demonstrates a link between GDM and vascular dysfunction in the decade following pregnancy, the mechanisms mediating this persistent dysfunction remain unexamined.

The purpose of this investigation is to examine the role of endothelin-1, a potent vasoconstrictor, in aberrant microvascular function in otherwise healthy women with a history of GDM and to identify whether this mechanism is influenced by physical activity and sedentary behavior.

Being studied: Insulin aspart

Conditions: Gestational Diabetes; Endothelial Dysfunction; Physical Inactivity

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

INCLUSION CRITERIA

  • history of pregnancy within 5 years of the study visit
  • had healthy pregnancy OR had gestational diabetes diagnosed by their obstetrician and confirmed according to the American College of Obstetricians and Gynecologists criteria for gestational diabetes.

EXCLUSION CRITERIA

  • skin diseases,
  • current tobacco or electronic cigarette/vape pen use,
  • diagnosed or suspected hepatic or metabolic disease including diabetes,
  • statin or other cholesterol-lowering medication,
  • current antihypertensive medication,
  • history of preeclampsia or gestational hypertension
  • current hypertension,
  • current pregnancy,
  • body mass index \<18.5 kg/m2,
  • allergy to materials used during the experiment.(e.g. latex), known allergies to study drugs.

Recruiting US locations

  • University of Iowa

    Iowa City, IA 52242

    Site contact: Anna Stanhewicz, PhD · 319-467-1732 · anna-stanhewicz@uiowa.edu

Study contacts (from the official record)

  • Anna Reid-Stanhewicz, PHD · 319-467-1732 · anna-stanhewicz@uiowa.edu
All diabetes studies in Iowa →
Role of ET-1, Physical Activity, and Sedentary Behavior in… (NCT06547619) | Bored Studies